Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Wheelersburg › NPI 1922150044
Physician

Wheelersburg Medical Associates

Wheelersburg Medical Associates was paid $531K by Medicaid between Jan 2018 and Dec 2024, across 21 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 46% of everything it billed.

33Billing provider infoWHEELERSBURG MEDICAL ASSOCIATES
WHEELERSBURG, OH 45694
33aNPI1922150044assigned 01/17/2007
28Total paid$531K
24GClaims14,924
24DCodes billed21
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Family Medicine Physician providers in Ohio

Rank by total paid#103 of 739
Median peer was paid$30K
This provider vs. median18×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018312$2K
20192,020$3K
20202,416$38K
20211,876$75K
20222,613$98K
20232,804$152K
2024incomplete2,883$163K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 46% 8,938 6,661 $242K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 22% 816 783 $115K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 20% 2,576 2,353 $104K
95909 6.4% 748 388 $34K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3.4% 694 493 $18K
95926 1.2% 280 209 $6K
95925 1.1% 194 155 $6K
93923 <1% 40 12 $2K
95923 <1% 40 12 $881.82
96004 <1% 203 56 $794.00
95924 <1% 20 12 $737.91
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 26 26 $691.03
9 more codes
96130 <1% 47 $611.19
96132 <1% 47 $282.87
96127 <1% 75 $187.16
96138 <1% 47 $49.82
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes <1% 30 $28.74
80305 <1% 19 $14.00
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 46 $2.09
96103 0% 18 $0.00
93040 0% 20 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCGINNIS, JAMES (OWNER)